Lymphadenectomy in elderly patients with high-intermediate-risk, high-risk or advanced endometrial cancer Time to move from personalized cancer medicine to personalized patient medicine!

Adélaïde Racin (1, 2) , Emilie Raimond , Sofiane Bendifallah (3) , Krystel Nyangoh Timoh (1) , Lobna Ouldamer (4) , Geoffroy Canlorbe (3) , Nina Hudry (5) , Charles Coutant (5) , Olivier Graesslin (6) , Cyril Touboul (7) , Pierre Collinet (8) , Alexandre Bricou (9, 10) , Cyrille Huchon (11) , Martin Koskas (12) , Marcos Ballester (13) , Emile Daraï (13) , Jean Leveque (1, 2) , Vincent Lavoue (1, 2)

1 CHU Pontchaillou [Rennes]
2 COSS - Chemistry, Oncogenesis, Stress and Signaling
3 DS3 - ESIM - Déterminants Sociaux de la Santé et du Recours aux Soins
4 Hôpital Bretonneau
5 UNICANCER/CRLCC-CGFL - Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon]
6 CHRU Tours - Centre Hospitalier Régional Universitaire de Tours
7 CHI Créteil
8 CHRU Lille - Centre Hospitalier Régional Universitaire [Lille]
9 Hôpital Jean Verdier [AP-HP]
10 UP13 - Université Paris 13
11 CHI Poissy-Saint-Germain
12 CIC - CHU Bichat
13 CRSA - Centre de Recherche Saint-Antoine

Keywords: Surgery; High-risk endometrial cancer; Cancer-specific survival; Elderly; Lymphadenectomy

Domains: Life Sciences [q-bio]; Cancer; Life Sciences [q-bio]; Human health and pathology; Gynecology and obstetrics; Life Sciences [q-bio]; Human health and pathology; Surgery

Adélaïde Racin, Emilie Raimond, Sofiane Bendifallah, Krystel Nyangoh Timoh, Lobna Ouldamer, et al.. Lymphadenectomy in elderly patients with high-intermediate-risk, high-risk or advanced endometrial cancer Time to move from personalized cancer medicine to personalized patient medicine!. EJSO - European Journal of Surgical Oncology, 2019, 45 (8), pp.1388-1395. ⟨10.1016/j.ejso.2019.02.015⟩. ⟨hal-02088077⟩